6 November 2018 15:08:18When will the vaccine become widely available?
The answer is not immediately clear.
The first phase of a new generation of vaccines has been under development for nearly a decade.
The government says it will start vaccinating people at least two weeks before the coronivirus pandemic officially starts, and in December, the first batch of vaccines will be given to those who are eligible.
But there is no set date, and the first doses will be distributed on a “waiver basis”, meaning they will only be given if someone can prove they need the vaccine.
In October, the UK announced it was considering extending the first vaccine period to include the second.
The delay has been blamed on the coronovirus, but also on a lack of access to the vaccines.
The UK government also says it has made progress in securing supply.
In May, the United States announced a second dose of the vaccine, with the first scheduled to be made available on October 30.
The US also has a third vaccine in the pipeline, with its first batch due to be given in early November.
The world’s largest vaccine manufacturer, GlaxoSmithKline, is also in talks with the UK and the US.
Meanwhile, some of the world’s biggest vaccine makers are also hoping to secure supply.
Last month, a group of global pharmaceutical companies, including GlaxosmithKline and Sanofi, announced they had agreed to jointly supply two doses of the first-ever vaccine for the pandemic.
However, those talks have now been put on hold.
The US government has not said when it will officially begin to distribute the vaccines, and it is unclear whether it will do so with or without the UK government’s help.
What happens next?
There are no guarantees that the pandivirus will be contained.
In a recent report, the UN Office for the Coordination of Humanitarian Affairs (OCHA) warned that the spread of the pandillae virus has now spread to areas in Europe and the Americas, with thousands of deaths reported worldwide.
The pandemic has also triggered an unprecedented rise in COVID-19 cases, with an estimated 4.2 million people now living with the disease.
Many of those cases have been linked to air travel, as the virus spreads by airborne droplets from the same infected air carrier.
The WHO estimates that 1.7 million people worldwide have been infected with the virus, with 1.1 million deaths.